Table of Contents
Metal-Based Drugs
Volume 2008 (2008), Article ID 217573, 10 pages
http://dx.doi.org/10.1155/2008/217573
Research Article

Synthesis and Anchoring of Antineoplastic Ferrocene and Phthalocyanine Derivatives on Water-Soluble Polymeric Drug Carriers Derived from Lysine and Aspartic Acid

1Department of Chemistry, University of the Free State, Bloemfontein 9300, South Africa
2School of Chemistry, University of the Witwatersrand, PO WITS 2050, South Africa

Received 25 July 2007; Accepted 1 October 2007

Academic Editor: Michael J. Cook

Copyright © 2008 M. David Maree et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Sherman and S. J. Lippard, “Structural aspects of platinum anticancer drug interactions with DNA,” Chemical Reviews, vol. 87, no. 5, pp. 1153–1181, 1987. View at Publisher · View at Google Scholar
  2. J. M. Ward, M. E. Grabin, E. Berlin, and D. M. Young, “Prevention of renal failure in rats receiving cis diamminedichloroplatinum(II) by administration of furosemide,” Cancer Research, vol. 37, no. 4, pp. 1238–1240, 1977. View at Google Scholar
  3. M. Rozencweig, D. D. Von Hoff, M. Slavik, and F. M. Muggia, “Cis diamminedichloroplatinum (II). A new anticancer drug,” Annals of Internal Medicine, vol. 86, no. 6, pp. 803–812, 1977. View at Google Scholar
  4. M. F. Pera, B. C. Zook, and H. C. Harder, “Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats,” Cancer Research, vol. 39, no. 4, pp. 1269–1278, 1979. View at Google Scholar
  5. W. R. Leopold, E. C. Miller, and J. A. Miller, “Carcinogenicity of antitumor cis-platinum(II) coordination complexes in the mouse and rat,” Cancer Research, vol. 39, no. 3, pp. 913–918, 1979. View at Google Scholar
  6. R. Duncan and J. Kopeček, “Soluble synthetic polymers as potential drug carriers,” Advances in Polymer Science, vol. 57, pp. 51–101, 1984. View at Publisher · View at Google Scholar
  7. W. Wolf and R. C. Manaka, “Synthesis and distribution of P195t(m) cis dichlorodiammine platinum(II),” Journal of Clinical Hematology and Oncology, vol. 7, no. 1, pp. 79–95, 1977. View at Google Scholar
  8. M. K. Wolpert-DeFillippes, “Antitumor activity of cis-dichlorodiammineplatinum(II),” Cancer Treatment Report, vol. 63, pp. 1453–1458, 1979. View at Google Scholar
  9. G. B. Pierce, “Differentiation of normal and malignant cells,” Federation Proceedings, vol. 29, no. 3, pp. 1248–1254, 1970. View at Google Scholar
  10. E. Cohen and W. Liang, in Membranes and Neoplasia, V. Marchesi, Ed., p. 23, Alan R. Liss, New York, NY, USA, 1976.
  11. J. H. Burchenal, K. Kalaher, T. O'Toole, and J. Chisholm, “Lack of cross resistance between certain platinum coordination compounds in mouse leukemia,” Cancer Research, vol. 37, no. 9, pp. 3455–3457, 1977. View at Google Scholar
  12. J. H. Burchenal, K. Kalaher, K. Dew, L. Lokys, and D. G. Gale, “Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivatives,” Biochimie, vol. 60, no. 9, pp. 961–965, 1978. View at Publisher · View at Google Scholar
  13. P. Köpf-Maier and H. Köpf, “Non-platinum-group metal antitumor agents: history, current status, and perspectives,” Chemical Reviews, vol. 87, no. 5, pp. 1137–1152, 1987. View at Google Scholar
  14. G. R. Gale, L. M. Atkins, and S. J. Meischen, “Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents,” Cancer Treatment Reports, vol. 61, no. 3, pp. 445–450, 1977. View at Google Scholar
  15. P. Köpf-Maier, H. Köpf, and E. W. Neuse, “Ferricenium complexes: a new type of water-soluble antitumor agent,” Journal of Cancer Research and Clinical Oncology, vol. 108, no. 3, pp. 336–340, 1984. View at Publisher · View at Google Scholar
  16. W. M. Sharman, C. M. Allen, and J. E. van Lier, “Photodynamic therapeutics: basic principles and clinical applications,” Drug Discovery Today, vol. 4, no. 11, pp. 507–517, 1999. View at Publisher · View at Google Scholar
  17. H. Ali, R. Langlois, J. R. Wagner, N. Brasseur, B. Paquette, and J. E. van Lier, “Biological activities of phthalocyanines—X: syntheses and analyses of sulfonated phthalocyanines,” Photochemistry and Photobiology, vol. 47, no. 5, pp. 713–717, 1988. View at Google Scholar
  18. I. Rosenthal and E. Ben-Hur, “Developments in photobiology of phthalocyanines,” in Phthalocyanines, Properties and Applications, C. C. Leznoff and A. B. P. Lever, Eds., vol. 1, p. 416, VCH, New York, NY, USA, 1989. View at Google Scholar
  19. P. J. Kelleher, H. L. Mathews, G. E. Moore, and P. Minden, “The use of cellular immunoadsorbents to prepare polyclonal antibodies that distinguish between antigens derived from human melanoma cells and autologous lymphocytes,” Cancer Immunology, Immunotherapy, vol. 14, no. 3, pp. 191–195, 1983. View at Publisher · View at Google Scholar
  20. M. B. Omary, I. S. Trowbridge, and J. Minowada, “Human cell-surface glycoprotein with unusual properties,” Nature, vol. 286, no. 5776, pp. 888–891, 1980. View at Publisher · View at Google Scholar
  21. A. Abuchowski, T. van Es, N. C. Palczuk, and F. F. Davis, “Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol,” Journal of Biological Chemistry, vol. 252, no. 11, pp. 3578–3581, 1977. View at Google Scholar
  22. U. Chiba, E. W. Neuse, J. C. Swarts, and G. J. Lamprecht, “Water-soluble polyamides as potential drug carriers—VII: synthesis of polymers containing intrachain- or extrachain-type amine ligands by interfacial polymerization,” Angewandte Makromolekulare Chemie, vol. 214, no. 1, pp. 137–152, 1994. View at Publisher · View at Google Scholar
  23. A. S. J. Stewart and C. N. C. Drey, “Selective protection of cysteine with ferrocene derivatives—part 2: synthesis of glutathione,” Journal of the Chemical Society-Perkin Transactions, no. 1, pp. 1753–1756, 1990. View at Publisher · View at Google Scholar
  24. H. Ringsdorf, “Structure and properties of pharmacologically active polymers,” Journal of Polymer Science, vol. 51, pp. 135–153, 1975. View at Google Scholar
  25. E. W. Neuse, “Macromolecular ferrocene compounds as cancer drug models,” Journal of Inorganic and Organometallic Polymers, vol. 15, no. 1, pp. 3–31, 2005. View at Publisher · View at Google Scholar
  26. J. C. Swarts, E. W. Neuse, and G. J. Lamprecht, “Synthesis and characterization of water-soluble polyaspartamide-ferrocene conjugates for biomedical applications,” Journal of Inorganic and Organometallic Polymers, vol. 4, no. 2, pp. 143–153, 1994. View at Publisher · View at Google Scholar
  27. J. C. Swarts, D. M. Swarts, M. D. Maree, E. W. Neuse, C. La Madeleine, and J. E. van Lier, “Polyaspartamides as water-soluble drug carriers—part 1: antineoplastic activity of ferrocene-containing polyaspartamide conjugates,” Anticancer Research, vol. 21, no. 3B, pp. 2033–2037, 2001. View at Google Scholar
  28. R. Duncan, D. Starling, F. Rypacek, J. Drobnik, and J. B. Lloyd, “Pinocytosis of poly(α,β-(N-2-hydroxyethyl)-DL-aspartamide and a tyramine derivative by rat visceral yolk sacs cultured in vitro. Ability of phenolic residues to enhance the rate of pinocytic capture of macromolecule,” Biochimica et Biophysica Acta, vol. 717, no. 2, pp. 248–254, 1982. View at Google Scholar
  29. F. Weygand and R. Geiger, “N-Trifluoracetyl-aminosäuren—IV: Mitteil.: N-Trifluoracetylierung von Aminosäuren in wasserfreier Trifluoressigsäure,” Chemische Berichte, vol. 89, no. 3, pp. 647–652, 1956. View at Publisher · View at Google Scholar
  30. E. E. Schallenberg and M. Calvin, “Ethyl thioltrifluoroacetate as an acetylating agent with particular reference to peptide synthesis,” Journal of the American Chemical Society, vol. 77, no. 10, pp. 2779–2783, 1955. View at Publisher · View at Google Scholar
  31. H. Meislich, H. Nechamkin, and J. Sharefkin, Theory and problems of Organic Chemistry, Schaum's Outline Series, McGraw-Hill, New York, NY, USA, 1980.
  32. J. Calam, Clinicias' Guide to Helicobacter Pylori, Chapman and Hall Medical, London, UK, 1996.
  33. T. Nogrady, Medicinal Chemistry, Oxford University Press, New York, NY, USA, 1988.
  34. C. de Duve, T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof, “Commentary. Lysosomotropic agents,” Biochemical Pharmacology, vol. 23, no. 18, pp. 2495–2531, 1974. View at Google Scholar
  35. P. da Re and E. Sianesi, “Condensation reactions of formyl- and acetyl-ferrocene,” Experientia, vol. 21, no. 11, pp. 648–649, 1965. View at Publisher · View at Google Scholar
  36. H. Shirai, M. Maruyama, K. Kobayashi, N. Hojo, and K. Urushido, “Functional metal-porphyrazine derivatives and their polymers .4. synthesis of poly(styrene) bonded Fe(III)-4,4',4'',4''' as well as Co(II)-4,4',4'',4'''-tetracarboxyphthalocyanine and their catalase-like activity,” Makromolekulare Chemie-Macromolecular Chemistry And Physics, vol. 181, p. 575, 1980. View at Google Scholar
  37. G. R. Gale, L. M. Atkins, S. J. Meischen, and P. Schwartz, “Synergistic action of high dose hydroxyurea when used with cyclophosphamide and certain new organoplatinum complexes in treatment of advanced L1210 leukemia,” Cancer, vol. 41, no. 4, pp. 1230–1234, 1978. View at Publisher · View at Google Scholar